HOYA Corporation
Stock Price Chart
2026/08/07 UpdatedPrice Trend
2026/08/07 UpdatedPrice & Trading Details
2026/08/07 UpdatedPRICE
TRADING
Analyst Recommendations 16 analysts
Updated 2026/08/01Earnings Calendar
Updated 2026/08/01Recent Earnings
| Date | EPS Est. | EPS Actual | Surprise |
|---|---|---|---|
| 2026/07/30 | ¥180.97 | ¥196.61 | +8.6% |
| 2026/04/29 | ¥173.43 | ¥160.80 | -7.3% |
| 2026/01/29 | ¥165.25 | ¥270.54 | +63.7% |
| 2025/10/30 | ¥159.25 | ¥161.96 | +1.7% |
Shareholder Composition
Updated 2026/08/01Top Mutual Funds / ETFs
Updated 2026/08/01Major Holders
Updated 2026/08/01| Fund Name | Ownership | Shares | Change |
|---|---|---|---|
|
VANGUARD STAR FUNDS-Vanguard Total International Stock Index Fund
|
4.9M | -1.39% | |
|
VANGUARD TAX-MANAGED FUNDS-Vanguard Developed Markets Index Fund
|
3.2M | +1.01% | |
|
iShares Trust-iShares Core MSCI EAFE ETF
|
2.5M | +0.74% | |
|
Fidelity Investment Trust-Fidelity Series Overseas Fund
|
2.0M | +2.33% | |
|
iShares, Inc.-iShares MSCI Japan ETF
|
1.5M | +6.12% | |
|
Fidelity Investment Trust-Fidelity Series International Growth Fund
|
1.3M | -5.07% |
| Institution | Ownership | Shares | Change |
|---|---|---|---|
|
Pacer Advisors, Inc.
|
2.9K | +4.69% | |
|
Paradigm Asset Management Company, LLC
|
10.0K | 0.00% |
Dividend History
Updated 2026/08/09| Year | Dividend | Change |
|---|---|---|
| 2026 | ¥170 | -29.2% |
| 2025 | ¥240 | +118.2% |
| 2024 | ¥110 | 0.0% |
| 2023 | ¥110 | 0.0% |
| 2022 | ¥110 | - |
Financial Performance
2026/08/09 UpdatedRevenue & Profit
Margins
Cash Flow
Financial Health
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Income Statement | ||||
| Revenue | ¥670,325M | ¥734,095M | ¥792,628M | ¥885,815M |
| Gross Profit | ¥567,283M | ¥631,855M | ¥687,990M | ¥766,251M |
| Operating Income | ¥363,472M | ¥400,864M | ¥433,453M | ¥480,792M |
| Pretax Income | ¥212,370M | ¥217,648M | ¥238,489M | ¥261,424M |
| Net Income | ¥164,507M | ¥168,638M | ¥181,376M | ¥202,102M |
| EPS | ¥445.93 | ¥469.47 | ¥515.27 | - |
| Operating Margin | 54.22% | 54.61% | 54.69% | 54.28% |
| Balance Sheet | ||||
| Total Assets | ¥992,839M | ¥1,028,326M | ¥1,203,623M | ¥1,234,278M |
| Total Equity | ¥803,851M | ¥818,321M | ¥967,758M | ¥974,023M |
| Total Liabilities | ¥188,988M | ¥210,005M | ¥235,865M | ¥260,255M |
| Cash | ¥419,404M | ¥405,888M | ¥525,162M | ¥533,967M |
| Interest-bearing Debt | ¥21,600M | ¥24,582M | ¥29,239M | ¥37,283M |
| Equity Ratio | 80.96% | 79.58% | 80.40% | 78.91% |
| D/E Ratio | 0.03 | 0.03 | 0.03 | 0.04 |
| Cash Flow | ||||
| Operating CF | ¥190,055M | ¥201,829M | ¥222,802M | ¥235,113M |
| Investing CF | -¥29,298M | -¥47,496M | -¥35,808M | -¥33,192M |
| Financing CF | -¥106,722M | -¥194,593M | -¥110,892M | -¥190,352M |
| Free CF | ¥161,183M | ¥168,356M | ¥181,728M | ¥187,191M |
| Efficiency | ||||
| ROE | 20.46% | 20.61% | 18.74% | 20.75% |
| ROA | 16.57% | 16.40% | 15.07% | 16.37% |
Latest IR Information
-
HOYA Financial Results Explanation Materials as of July 31, 2026
HOYA achieved net sales of approximately 770 billion yen in Q1 2026, representing an increase of about 23% YoY. All business segments showed steady growth, with optical solutions and endoscopy businesses performing particularly well. Shareholder return measures such as share...
Read more -
Decision on Share Buyback | July 31, 2026
HOYA plans to conduct a share buyback of up to 10 million shares (approximately 2.99%) with a total amount of 200 billion yen, aiming to enhance shareholder returns and capital efficiency. The repurchase period is from August 3, 2026, to...
Read more -
[HOYA] Q1 FY2027 Earnings Results | Revenue of 255.7 billion yen (+16% YoY)
HOYA achieved net sales of 255.7 billion yen and operating income of 82.6 billion yen in the first quarter of fiscal year 2027, recording significant YoY growth in both revenue and profit. Segments such as Healthcare and Information & Communications...
Read more -
HOYA Financial Summary｜Q2 Performance for Fiscal Year ending July 2026 and Future Outlook
HOYA achieved net sales of 220.4 billion yen (YoY 16.0% increase) and operating income of 63.5 billion yen (same period 30.0% increase) in the second quarter of fiscal year ending June 2026. Segment-wise, the Healthcare Business remains strong, and full-year...
Read more -
Start of Strategic Options Review for Medical Endoscopy Business｜July 2026
HOYA has begun considering strategic options for its medical endoscopy business and plans to spin off the domestic operations into a separate company on August 1, 2026. Future policies and impacts are undecided.
Read more
Latest News (5 items)
-
Average Analyst Rating: strong_buy
Average Target Price: ¥30,247
Rating Score: 1.50 (Based on 16 analysts)
※1=Strong Buy, 5=Strong Sell
Company Information
About
HOYA Corporation, a med-tech company, provides high-tech and medical products in the Japan, Asia, the Americas, Europe, and internationally. The company operates through two segments: Life Care, and Information and Communications. It offers life care products, including eyeglasses; contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics, brain surgery, and dentistry. The company also operates Eyecity, a specialty retailer of contact lenses. In addition, it provides information technology products, such as mask blanks and photomasks for manufacturing semiconductor chips; glass disks for hard disk drives; and imaging related products that comprise optical glasses/optical lenses, colored glass filters, and UV light resources. Further, the company engages in research, development, manufacture, and sale of photomasks for manufacturing flat panel displays. HOYA Corporation was founded in 1941 and is headquartered in Shinjuku, Japan.
